Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences.
about
Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathyThe Evolution of the Stem Cell Theory for Heart FailureStem cell-based therapies for the newborn lung and brain: Possibilities and challengesCell Therapy in Patients with Critical Limb IschemiaCell based therapies for ischemic stroke: from basic science to bedsideSecreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repairSpatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications.Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery diseaseBone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products.Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic conditionA combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cellsEvidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia.Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesisThe collateral circulation of the heart.Single cell gene profiling revealed heterogeneity of paracrine effects of bone marrow cells in mouse infarcted hearts.Promotion of transplanted bone marrow-derived cell migration into the periodontal tissues due to orthodontic mechanical stress.SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability.Surface Phosphatidylserine Is Responsible for the Internalization on Microvesicles Derived from Hypoxia-Induced Human Bone Marrow Mesenchymal Stem Cells into Human Endothelial Cells.Stem cell therapy for the heart.Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice.EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1.Cardiac stem cells and mechanisms of myocardial regeneration.Bone marrow mononuclear cells induce beneficial remodeling and reduce diastolic dysfunction in the left ventricle of hypertensive SS/MCWi ratsDrosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells.Bone marrow-derived stem cell therapy in ischemic heart disease.Adult stem cells and heart regeneration.X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease.Therapeutic angiogenesis with bone marrow--derived stem cells.Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats.Leukocyte-mimicking stem cell delivery via in situ coating of cells with a bioactive hyperbranched polyglycerol.G-CSF- and erythropoietin-based cell therapy: a promising strategy for angiomyogenesis in myocardial infarction.Constitutive stabilization of hypoxia-inducible factor alpha selectively promotes the self-renewal of mesenchymal progenitors and maintains mesenchymal stromal cells in an undifferentiated stateCardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.Monocyte transplantation for neural and cardiovascular ischemia repairLong-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up.Cell therapy with bone marrow cells for myocardial regeneration.
P2860
Q24672544-445E949C-9F72-4337-91B1-F6BE091E121CQ26769042-9FB606EA-C765-4147-BB78-04129191B9CAQ26771562-EEDFEA5D-2674-4E49-A014-5CF952D614E3Q26795443-0D13AE70-1CF9-4A18-91C2-96246FBAAF9FQ27025754-31EF586B-1DE9-45E5-844A-E04C0D95B807Q28587325-E2E14680-4B46-4EB4-A4E5-4C830D47BDE3Q30430026-30CD6D7B-01CF-4F59-B6A4-56B15E69C909Q33462060-246A8C0D-F760-4EDB-9F6C-D9D18E652EABQ33753521-D9D4B9DA-9600-4822-B67A-C0B57F94EAF4Q33942087-B4279AD1-5492-448A-AABD-C8C5A56959FFQ33950008-DA6AA0FB-3016-43CF-85D6-7E3E0AA9921BQ34235133-93583EC2-1E0A-46CA-B5F1-699AEA16984AQ34355986-0AA45EFC-AAAB-4036-AC4D-02A6CEF4A22AQ34485563-225A5ED6-0166-4CE5-989B-73141CB8B452Q34756631-BCE74732-BCF2-4209-ACA9-7A477A1DEF1EQ34827093-299793C6-7070-4680-B1C0-9509EB8F2C90Q34975463-F78693AF-A2EA-4F06-8902-6CC7F3414FFBQ35009602-487E7CA0-7806-4A78-A059-01C32F49C506Q35204126-89D9E576-EEBC-46AC-9AC9-719410DDDCBBQ35903711-8081AF88-DC67-42BE-85F3-791D6DC276C0Q35980614-78FE11A1-45A9-46E2-B909-4D0019638C3BQ36173615-07C573CF-B1E8-4572-AD06-6BC1593F877EQ36181266-B3867F4D-9595-49AE-AA5D-FA45C644931FQ36267790-7005A675-08BD-4850-B4FB-B4F9B735D755Q36320712-850CCBC7-9F3E-4DB6-8B44-FA23B7AD9675Q36333354-64EDC5E5-1B2D-4C8F-A007-27BB9CFC0003Q36486356-54B265EB-8949-41D0-B54C-6966E6787401Q36804551-85E0B158-2B77-4E7D-A70B-7E3FCD062129Q36815983-AE174751-F80C-4919-8CAA-89B4A409B6B4Q36842323-D88556EA-0793-480C-907C-6C176E0EAA04Q36847077-3D52A4E7-C4FF-4EE6-944B-3350F5BA9E46Q36930468-6DDAE121-0FC0-4B98-A3B7-FA53AEC4E1B7Q36943782-3CBBD13F-56CE-4C50-8CD8-EE9F2EEEAE7AQ36944945-2E46C9AF-A639-4C5F-80F6-A986766297ABQ37176449-CA98CD41-7415-49B3-8FB3-CC84931D5B02Q37212195-EF17C653-2D65-49EF-BD80-51BC00D19EB9Q37253735-C7ED1E87-CD91-4EBC-B596-DED8D45DE32FQ37296292-11E0ACEC-5C96-4823-AAA7-E8C10AC98485Q37305343-7D4E78F9-3FBD-4F3D-9F56-C37B78F84B57Q37388609-9CD76BA3-ED05-44AE-A7E9-0AAE85D5153D
P2860
Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Bone-marrow-derived cells for ...... initial clinical experiences.
@ast
Bone-marrow-derived cells for ...... initial clinical experiences.
@en
type
label
Bone-marrow-derived cells for ...... initial clinical experiences.
@ast
Bone-marrow-derived cells for ...... initial clinical experiences.
@en
prefLabel
Bone-marrow-derived cells for ...... initial clinical experiences.
@ast
Bone-marrow-derived cells for ...... initial clinical experiences.
@en
P2093
P1433
P1476
Bone-marrow-derived cells for ...... initial clinical experiences.
@en
P2093
Eugenio Stabile
Mary Susan Burnett
Stephen E Epstein
Tim Kinnaird
P304
P356
10.1161/01.RES.0000137878.26174.66
P577
2004-08-01T00:00:00Z